375 related articles for article (PubMed ID: 9042560)
1. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Compan D; Saliba E; Weisslinger N; Huet Y
Drugs; 1996; 52 Suppl 7():47-54. PubMed ID: 9042560
[TBL] [Abstract][Full Text] [Related]
2. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.
Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Huet Y
Lancet; 1996 Jul; 348(9022):224-8. PubMed ID: 8684199
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group.
Planès A; Vochelle N; Fagola M; Bellaud M
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):499-505. PubMed ID: 9819000
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
[TBL] [Abstract][Full Text] [Related]
5. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
Nilsson PE; Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlund U; Nicolas S; Nylander G
Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404
[TBL] [Abstract][Full Text] [Related]
6. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
[TBL] [Abstract][Full Text] [Related]
7. The post-hospital discharge venous thrombosis risk of the orthopedic patient.
Planes A; Vochelle N
Orthopedics; 1997 Feb; 20 Suppl():18-21. PubMed ID: 9048403
[TBL] [Abstract][Full Text] [Related]
8. Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trial.
Kalodiki EP; Hoppensteadt DA; Nicolaides AN; Fareed J; Gill K; Regan F; al-Kutoubi A; Cunningham DA; Birch R; Harris N; Hunt D; Johnson J; Marx C
Int Angiol; 1996 Jun; 15(2):162-8. PubMed ID: 8803642
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Rosencher N; Kurth AA; van Dijk CN; Frostick SP; Prins MH; Hettiarachchi R; Hantel S; Schnee J; Büller HR;
Lancet; 2007 Sep; 370(9591):949-56. PubMed ID: 17869635
[TBL] [Abstract][Full Text] [Related]
10. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
Marlovits S; Striessnig G; Schuster R; Stocker R; Luxl M; Trattnig S; Vécsei V
Arthroscopy; 2007 Jul; 23(7):696-702. PubMed ID: 17637403
[TBL] [Abstract][Full Text] [Related]
11. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
12. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
[TBL] [Abstract][Full Text] [Related]
13. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
Kakkar AK; Brenner B; Dahl OE; Eriksson BI; Mouret P; Muntz J; Soglian AG; Pap AF; Misselwitz F; Haas S;
Lancet; 2008 Jul; 372(9632):31-9. PubMed ID: 18582928
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
Spiro TE; Johnson GJ; Christie MJ; Lyons RM; MacFarlane DE; Blasier RB; Tremaine MD
Ann Intern Med; 1994 Jul; 121(2):81-9. PubMed ID: 8017740
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
[TBL] [Abstract][Full Text] [Related]
16. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
17. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
18. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G
N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538
[TBL] [Abstract][Full Text] [Related]
19. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
20. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Hornick P;
Lancet; 2010 Mar; 375(9717):807-15. PubMed ID: 20206776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
